Archives of Virology

, 153:1921 | Cite as

Modification of adenovirus type 5 tropism for a preferential transduction of human papillomavirus-positive cancer cells

  • Magali Lagrange
  • Charlotte Boulade-Ladame
  • Georges Orfanoudakis
  • François Deryckere
Brief Report

Abstract

Human group C adenoviruses can infect many cell types, and this is due to the widespread expression of their receptor, the coxsackievirus and adenovirus receptor (CAR). Adenovirus vectors for cancer gene therapy could be significantly improved if their tropism were restricted to tumor cells. In this work, previously identified peptides that target human papillomaviruses (HPV)-transformed cells were inserted into the HI loop of a non-CAR-binding fiber. These modified fiber proteins were able to assemble into adenovirus particles. We demonstrated that these modifications ablated the native tropism of adenovirus type 5, and these modified adenoviruses were shown to preferentially transduce HPV-transformed cell lines.

Notes

Acknowledgments

We acknowledge Dan J. Von Seggern (TSRI, La Jolla, CA, USA) for providing us reagents. We thank Philip Robinson (Département de Pharmacologie, Université Victor Ségalen Bordeaux 2, Bordeaux, France) for critical reading of the manuscript. This work was supported by the ULP, CNRS, ARC, the Ligue Nationale Contre Le Cancer Comité du Haut Rhin and the Cancéropôle-Grand-EST. M.L. and C.B-L. were supported by scholarships of the Ministère de la Recherche (M.L. and C.B-L.) and the Ligue Régionale Contre le Cancer (ML).

References

  1. 1.
    Belousova N, Krendelchtchikova V, Curiel DT, Krasnykh V (2002) Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein. J Virol 76:8621–8631PubMedCrossRefGoogle Scholar
  2. 2.
    Bewley MC, Springer K, Zhang YB, Freimuth P, Flanagan JM (1999) Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science 286:1579–1583PubMedCrossRefGoogle Scholar
  3. 3.
    Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, Mikheeva G, Belousova N, Curiel DT (1998) An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol 72:9706–9713PubMedGoogle Scholar
  4. 4.
    Jakubczak JL, Rollence ML, Stewart DA, Jafari JD, Von Seggern DJ, Nemerow GR, Stevenson SC, Hallenbeck PL (2001) Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells. J Virol 75:2972–2981PubMedCrossRefGoogle Scholar
  5. 5.
    Kirby I, Davison E, Beavil AJ, Soh CP, Wickham TJ, Roelvink PW, Kovesdi I, Sutton BJ, Santis G (2000) Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein. J Virol 74:2804–2813PubMedCrossRefGoogle Scholar
  6. 6.
    Leissner P, Legrand V, Schlesinger Y, Hadji DA, van Raaij M, Cusack S, Pavirani A, Mehtali M (2001) Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism. Gene Ther 8:49–57PubMedCrossRefGoogle Scholar
  7. 7.
    Mizuguchi H, Hayakawa T (2004) Targeted adenovirus vectors. Hum Gene Ther 15:1034–1044PubMedCrossRefGoogle Scholar
  8. 8.
    Nicklin SA, Von Seggern DJ, Work LM, Pek DC, Dominiczak AF, Nemerow GR, Baker AH (2001) Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus. Mol Ther 4:534–542PubMedCrossRefGoogle Scholar
  9. 9.
    Novelli A, Boulanger PA (1991) Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber. Virology 185:365–376PubMedCrossRefGoogle Scholar
  10. 10.
    Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRefGoogle Scholar
  11. 11.
    Robinson P, Stuber D, Deryckere F, Tedbury P, Lagrange M, Orfanoudakis G (2005) Identification using phage display of peptides promoting targeting and internalization into HPV-transformed cell lines. J Mol Recognit 18:175–182PubMedCrossRefGoogle Scholar
  12. 12.
    Roelvink PW, Mi Lee G, Einfeld DA, Kovesdi I, Wickham TJ (1999) Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science 286:1568–1571PubMedCrossRefGoogle Scholar
  13. 13.
    Santis G, Legrand V, Hong SS, Davison E, Kirby I, Imler JL, Finberg RW, Bergelson JM, Mehtali M, Boulanger P (1999) Molecular determinants of adenovirus serotype 5 fibre binding to its cellular receptor CAR. J Gen Virol 80(Pt 6):1519–1527PubMedGoogle Scholar
  14. 14.
    Von Seggern DJ, Kehler J, Endo RI, Nemerow GR (1998) Complementation of a fibre mutant adenovirus by packaging cell lines stably expressing the adenovirus type 5 fibre protein. J Gen Virol 79(Pt 6):1461–1468Google Scholar
  15. 15.
    Von Seggern DJ, Huang S, Fleck SK, Stevenson SC, Nemerow GR (2000) Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells. J Virol 74:354–362Google Scholar
  16. 16.
    Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19PubMedCrossRefGoogle Scholar
  17. 17.
    Zhang Y, Bergelson JM (2005) Adenovirus receptors. J Virol 79:12125–12131PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Magali Lagrange
    • 1
  • Charlotte Boulade-Ladame
    • 1
  • Georges Orfanoudakis
    • 1
  • François Deryckere
    • 1
  1. 1.UMR 7175, CNRS, Université Louis Pasteur, Oncoprotéines, ESBSIllkirch CedexFrance

Personalised recommendations